RU2018137547A3 - - Google Patents
Download PDFInfo
- Publication number
- RU2018137547A3 RU2018137547A3 RU2018137547A RU2018137547A RU2018137547A3 RU 2018137547 A3 RU2018137547 A3 RU 2018137547A3 RU 2018137547 A RU2018137547 A RU 2018137547A RU 2018137547 A RU2018137547 A RU 2018137547A RU 2018137547 A3 RU2018137547 A3 RU 2018137547A3
- Authority
- RU
- Russia
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0662—Stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4716—Muscle proteins, e.g. myosin, actin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0662—Stem cells
- C12N5/0663—Bone marrow mesenchymal stem cells (BM-MSC)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/02—Atmosphere, e.g. low oxygen conditions
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/36—Lipids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/14—Erythropoietin [EPO]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/30—Hormones
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/50—Cell markers; Cell surface determinants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/80—Neurotransmitters; Neurohormones
- C12N2501/825—Serotonine (5-HT); Melatonine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/85—Hormones derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
- C12N2501/86—Melanocyte-stimulating hormone [MSH]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/998—Proteins not provided for elsewhere
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/999—Small molecules not provided for elsewhere
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Developmental Biology & Embryology (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Cell Biology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Rheumatology (AREA)
- Hematology (AREA)
- Virology (AREA)
- Epidemiology (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Transplantation (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662316131P | 2016-03-31 | 2016-03-31 | |
| US62/316,131 | 2016-03-31 | ||
| PCT/US2017/025153 WO2017173150A1 (en) | 2016-03-31 | 2017-03-30 | Medium, methods, cells and secreted factors for stem cell culture and therapy |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| RU2018137547A RU2018137547A (en) | 2020-04-30 |
| RU2018137547A3 true RU2018137547A3 (en) | 2020-04-30 |
Family
ID=59965182
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2018137547A RU2018137547A (en) | 2016-03-31 | 2017-03-30 | ENVIRONMENT, METHODS, CELLS AND SECRET FACTORS FOR STEM CELL CULTURE AND THERAPY |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US11946072B2 (en) |
| EP (1) | EP3436570A4 (en) |
| JP (3) | JP7029407B2 (en) |
| KR (6) | KR20240047481A (en) |
| CN (1) | CN109219658A (en) |
| AU (3) | AU2017241807B2 (en) |
| CA (1) | CA3019574A1 (en) |
| RU (1) | RU2018137547A (en) |
| WO (1) | WO2017173150A1 (en) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20160095885A1 (en) | 2014-10-01 | 2016-04-07 | WibiWorks Therapeutics, Inc. | Induction Medium & Methods for Stem Cell Culture & Therapy |
| JP7168448B2 (en) | 2015-12-07 | 2022-11-09 | コロラド ステート ユニバーシティー リサーチ ファウンデーション | Compositions containing activated stem cells for infected wounds |
| KR20240047481A (en) | 2016-03-31 | 2024-04-12 | 샌바이오, 인크. | Medium, methods, cells and secreted factors for stem cell culture and therapy |
| JPWO2018159431A1 (en) * | 2017-03-03 | 2019-12-26 | ロート製薬株式会社 | Mesenchymal stem cell and liver disease therapeutic agent |
| EP3438250B1 (en) * | 2017-07-31 | 2022-12-07 | Rheinische Friedrich-Wilhelms-Universität Bonn | Cell derived extracellular vesicles for the treatment of diseases |
| KR102646145B1 (en) * | 2018-05-31 | 2024-03-11 | 주식회사 엑소코바이오 | Composition for reducing skin pore size comprising an exosome derived from stem cell as an active ingredient |
| US20210275596A1 (en) * | 2018-07-20 | 2021-09-09 | Cell2In, Inc. | Application of gene profile for cells isolated using fresh-tracer |
| EP3990625A4 (en) * | 2019-06-26 | 2023-07-19 | Technion Research & Development Foundation Limited | Production of extracellular vesicles from stem cells |
| CN114599380A (en) * | 2019-09-06 | 2022-06-07 | 美德邈医药公司 | Composition for preventing or treating salivary gland diseases using cell-derived vesicle |
| CN110946876A (en) * | 2019-10-28 | 2020-04-03 | 天津市康婷生物工程集团有限公司 | Application of mesenchymal stem cell exosome preparation in treating alopecia areata |
| IL272145A (en) * | 2020-01-20 | 2021-07-29 | Stem Cell Medicine Ltd | Cosmetic compositions with protein concentrate from conditioned medium of adipose-derived stem cells |
| CN111690686B (en) * | 2020-07-19 | 2021-01-15 | 广西康久生物科技有限公司 | Application of miRNA high expression in promoting in-vitro proliferation and osteogenic differentiation of umbilical cord mesenchymal stem cells |
| CN112143697B (en) * | 2020-10-08 | 2021-08-06 | 宁波希诺赛生物科技有限公司 | Method for promoting proliferation and differentiation of embryonic stem cells |
| WO2022080461A1 (en) * | 2020-10-16 | 2022-04-21 | 富士フイルム和光純薬株式会社 | Culture medium for producing extracellular vesicles, culture medium kit, additive, and method for producing extracellular vesicles |
| EP4257673A1 (en) * | 2020-12-04 | 2023-10-11 | Primoris Co., Ltd. | Method for preparing high-concentration stem cell exosomes with enhanced anti-inflammatory and regenerative functions using lipopolysaccharide and lipoteichoic acid |
| CN114763523A (en) * | 2020-12-30 | 2022-07-19 | 西比曼生物科技（上海）有限公司 | Method for increasing content of specific miRNA in human cell-derived extracellular vesicle |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZA200702434B (en) * | 2004-11-02 | 2008-08-27 | Ares Trading Sa | Serum-free cell culture medium for mammalian cells |
| KR20070070780A (en) * | 2005-12-29 | 2007-07-04 | 엘지전자 주식회사 | Door handle of washing machine |
| US9598673B2 (en) * | 2006-05-19 | 2017-03-21 | Creative Medical Health | Treatment of disc degenerative disease |
| EP3190178A1 (en) * | 2007-02-23 | 2017-07-12 | Astellas Institute for Regenerative Medicine | Highly efficient methods for reprogramming differentiated cells and for generating animals and embryonic stem cells from reprogrammed cells |
| AU2008323853B8 (en) * | 2007-11-08 | 2014-07-24 | Beth Israel Deaconess Medical Center | Stimulation of anti-tumor immunity using dendritic cell/tumor cell fusions and anti-CD3/CD28 |
| CN102741396B (en) * | 2009-04-27 | 2017-10-20 | 威盛细胞有限公司 | Support the small molecule and its method of pluripotent cell growth |
| JP2012031127A (en) * | 2010-08-03 | 2012-02-16 | Nagoya Univ | Composition including umbilical cord matrix stromal cell |
| US20140017787A1 (en) * | 2010-10-11 | 2014-01-16 | Aline M. Betancourt | Mesenchymal stem cells and related therapies |
| CN101984048A (en) * | 2010-11-24 | 2011-03-09 | 中国人民解放军军事医学科学院放射与辐射医学研究所 | Culture medium for culturing mesenchymal stem cells |
| US20120213754A1 (en) * | 2011-02-23 | 2012-08-23 | Stem Cell Partners Llc | Method of Preconditioning of Cell Suspensions |
| US9617517B2 (en) * | 2011-05-02 | 2017-04-11 | National University Corporation Kumamoto University | Small chemical compound which promotes induction of differentiation of stem cells into insulin-producing cells and method for inducing differentiation of stem cells into insulin-producing cells using said small chemical compound |
| ITRM20110403A1 (en) * | 2011-07-28 | 2013-01-29 | Ospedale Pediatrico Bambino Gesu | MICROWELES ISOLATED BY MESENCHIMAL CELLS AS IMMUNOSOPPRESSORS. |
| KR101532556B1 (en) * | 2012-09-03 | 2015-06-30 | 메디포스트(주) | Method for culturing mesenchymal stem cells |
| KR101415039B1 (en) * | 2013-09-30 | 2014-08-13 | 지엔에스바이오(주) | Medium Composition and Method for Massive Culture of Autologous Activated Lymphocyte |
| US20160095885A1 (en) * | 2014-10-01 | 2016-04-07 | WibiWorks Therapeutics, Inc. | Induction Medium & Methods for Stem Cell Culture & Therapy |
| CN104845933A (en) * | 2015-05-15 | 2015-08-19 | 大连理工大学 | Method for enhancing immunological performance and migration capacity of adipose mesenchymal stem cell |
| EP3355927B1 (en) * | 2015-09-30 | 2021-06-23 | The Administrators of the Tulane Educational Fund | Devices for supporting regeneration of body tissues, and methods of making and using them |
| KR20240047481A (en) | 2016-03-31 | 2024-04-12 | 샌바이오, 인크. | Medium, methods, cells and secreted factors for stem cell culture and therapy |
| KR101971323B1 (en) * | 2016-10-17 | 2019-04-23 | 사회복지법인 삼성생명공익재단 | Methods for Selecting Improved Stem Cell for Treating Immune Disease |
-
2017
- 2017-03-30 KR KR1020247010774A patent/KR20240047481A/en active Search and Examination
- 2017-03-30 KR KR1020217026047A patent/KR102409483B1/en active IP Right Grant
- 2017-03-30 CA CA3019574A patent/CA3019574A1/en active Pending
- 2017-03-30 AU AU2017241807A patent/AU2017241807B2/en active Active
- 2017-03-30 KR KR1020227032574A patent/KR102555611B1/en active IP Right Grant
- 2017-03-30 KR KR1020227019817A patent/KR102447145B1/en active IP Right Grant
- 2017-03-30 RU RU2018137547A patent/RU2018137547A/en not_active Application Discontinuation
- 2017-03-30 KR KR1020237023406A patent/KR20230108351A/en active IP Right Grant
- 2017-03-30 JP JP2018551264A patent/JP7029407B2/en active Active
- 2017-03-30 KR KR1020187031736A patent/KR102293012B1/en active Application Filing
- 2017-03-30 CN CN201780034143.6A patent/CN109219658A/en active Pending
- 2017-03-30 WO PCT/US2017/025153 patent/WO2017173150A1/en active Application Filing
- 2017-03-30 EP EP17776696.1A patent/EP3436570A4/en active Pending
-
2018
- 2018-09-28 US US16/147,229 patent/US11946072B2/en active Active
-
2021
- 2021-08-18 AU AU2021218073A patent/AU2021218073B2/en active Active
-
2022
- 2022-02-18 JP JP2022023751A patent/JP7336557B2/en active Active
-
2023
- 2023-08-21 JP JP2023134266A patent/JP2023156490A/en active Pending
- 2023-09-28 AU AU2023237128A patent/AU2023237128A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| AU2023237128A1 (en) | 2023-10-19 |
| EP3436570A1 (en) | 2019-02-06 |
| EP3436570A4 (en) | 2019-09-04 |
| JP2022070994A (en) | 2022-05-13 |
| KR102447145B1 (en) | 2022-09-23 |
| AU2021218073A1 (en) | 2021-09-09 |
| KR20220084438A (en) | 2022-06-21 |
| WO2017173150A1 (en) | 2017-10-05 |
| KR20230108351A (en) | 2023-07-18 |
| KR20180132785A (en) | 2018-12-12 |
| KR20240047481A (en) | 2024-04-12 |
| KR102409483B1 (en) | 2022-06-16 |
| RU2018137547A (en) | 2020-04-30 |
| JP2023156490A (en) | 2023-10-24 |
| US20190062710A1 (en) | 2019-02-28 |
| KR102293012B1 (en) | 2021-08-27 |
| US11946072B2 (en) | 2024-04-02 |
| JP2019513367A (en) | 2019-05-30 |
| JP7029407B2 (en) | 2022-03-03 |
| KR102555611B1 (en) | 2023-07-13 |
| CA3019574A1 (en) | 2017-10-05 |
| KR20210106014A (en) | 2021-08-27 |
| KR20220132058A (en) | 2022-09-29 |
| JP7336557B2 (en) | 2023-08-31 |
| AU2021218073B2 (en) | 2024-02-15 |
| AU2017241807A1 (en) | 2018-11-22 |
| AU2017241807B2 (en) | 2021-05-20 |
| CN109219658A (en) | 2019-01-15 |
Similar Documents
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA94 | Acknowledgement of application withdrawn (non-payment of fees) |
Effective date: 20220217 |